Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan
Authors:
- 1 September 2017
- journal article
- case report
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 23 (9) , 648-650
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitaliumNature Reviews Urology, 2017
- 2016 European guideline on Mycoplasma genitalium infectionsJournal of the European Academy of Dermatology and Venereology, 2016
- Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium-Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic RegimensClinical Infectious Diseases, 2014
- Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in JapanJournal of Antimicrobial Chemotherapy, 2014
- Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistanceInternational Journal of STD & AIDS, 2013
- Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritisJournal of Infection and Chemotherapy, 2013
- Antimicrobial chemotherapy ofMycoplasma genitalium-positive non-gonococcal urethritisExpert Review of Anti-infective Therapy, 2012
- Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacinJournal of Infection and Chemotherapy, 2012
- Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitaliumJournal of Infection and Chemotherapy, 2012
- Mycoplasma genitalium: from Chrysalis to Multicolored ButterflyClinical Microbiology Reviews, 2011